latest news releases from the newsroom
Cytomedix to Restate Previously Issued Financial Statements for Stock-Option Related Compensation
ROCKVILLE, Md., Nov. 7, 2007 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it will restate certain previously issued financial statements to correct for errors related to stock-based compensation. On November 5, 2007, Cytomedix determined that the financial statements for the fiscal year ended December 31, 2006, and for each of the quarters in 2006 and 2007, should no longer be relied upon because of errors in such financial statements. The Board of Directors has discussed this determination with the Company's management, outside counsel, its current registered public accounting firm, PricewaterhouseCoopers LLP, and its prior registered public accounting firm, L J Soldinger Associates, LLC.
Virgin America Announces New Service Between San Diego and San Francisco
SAN FRANCISCO, Nov. 7, 2007 (PRIME NEWSWIRE) -- Virgin America today announced ticket sales for daily flights between its home base of San Francisco International Airport (SFO) and San Diego International Airport (SAN). The service will begin on Feb 12, 2008 with three daily flights and will expand to five daily flights on March 9, 2008. Connecting flights will also be available from San Diego via SFO to New York's JFK and Washington Dulles airports.
FreeSeas Inc. Announces Delivery of the Handysize Free Goddess
PIRAEUS, Greece, Nov. 7, 2007 (PRIME NEWSWIRE) -- FreeSeas Inc. (Nasdaq:FREE) (Nasdaq:FREEW) (Nasdaq:FREEZ) ("FreeSeas" or "the Company"), a provider of seaborne transportation for drybulk cargoes, announced today that it had taken delivery of the 1995-built, 22,051 dwt Handysize M/V Free Goddess on October 30, 2007. The vessel then began a time charter at $13,000 per day, which is expected to last approximately one month. The vessel will thereafter begin a two-year time charter at $19,250 per day.
Cardio Infrared Technologies, Inc.
Cardio Infrared Technologies, Inc. Announces Clinical Trials
LAS VEGAS, Nov. 7, 2007 (PRIME NEWSWIRE) -- Cardio Infrared Technologies, Inc. (Pink Sheets:CIRT) announced today that Cardio Infrared Technologies, Inc. began clinical trials with Bucks County Clinical Research, Inc. (FDA Certified) and Dr. Richard M. Goldfarb, M.D., FACS. Bucks/Goldfarb will perform a Human Clinical Study on the "CardioCor(tm)" Exerbike equipment over a 12 week period. The study will be conducted on male and female patients who suffer from overweight and or excess cellulite and will position them in a full protocol of three 40-minute sessions for 12 weeks.